Last edition
News about "Newron evenamide"
Newron Provides Update on Phase 3 ENIGMA-TRS 2 Study
Newron’s ENIGMA-TRS 2 study continues outside the US, with expanded sites and enrollment in Europe, Asia and Latin America; topline data expected in Q1 2027.
Newron Evenamide | 28/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members